Mealey's (July 18, 2016, 1:17 PM EDT) -- CHARLESTON, S.C. — A South Carolina federal magistrate judge on July 14 recommended that 40 California cases be remanded from the Lipitor diabetes multidistrict litigation after finding that they are not mass actions under the Class Action Fairness Act (CAFA) and that the naming of drug distributor McKesson Corp. as a defendant has not been shown to be fraudulent misjoinder (In Re: Lipitor [Atorvastatin Calcium] Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2502, No. 14-mn-2502, D. S.C.)....